GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 6 analysts with an average price target of $35.15. This is a potential upside of $-5.88 (-14.33%) from yesterday's end of day stock price of $41.03.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 127 price targets and 86 ratings on display. The stock rating distribution of GSK is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.49% with an average time for these price targets to be met of 314.28 days.

Highest price target for GSK is $45, Lowest price target is $41, average price target is $43.33.

Most recent stock forecast was given by KERRY HOLFORD from BERENBERG on 02-Dec-2024. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of GSK, 3 are a HOLD (33.33%), 6 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$41

$-0.03 (-0.07%)

5 months 29 days ago
(02-Dec-2024)

1/1 (100%)

$6.69 (19.50%)

179

Hold

$53

6 months 19 days ago
(12-Nov-2024)

2/4 (50%)

$15.58 (41.64%)

379

Buy

9 months 30 days ago
(01-Aug-2024)

1/13 (7.69%)

$-10.5 (-32.65%)

64

Buy

$45

$3.97 (9.68%)

$47

10 months 15 days ago
(16-Jul-2024)

1/3 (33.33%)

$6.9 (18.11%)

2259

Buy

$19.52

1 years 3 months 18 days ago
(13-Feb-2024)

0/3 (0%)

$-13.88 (-41.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 314.28 days on average for the stock forecasts to be realized with a an average price target met ratio 25.49

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

JUSTIN SMITH

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Justin Smith works at SOCGEN and has 3 price targets and 2 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

John Eade with highest potential upside - $3.97

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

James Gordon with lowest potential downside - -$23.93

GlaxoSmithKline PLC ADR in the News

GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis

Premiering on Lifetime on June 28, 2025, at 8 p.m. ET/7 p.m. CT, Pretty Hurts, brought to you by GSK, features a storyline that aims to raise awareness among parents about meningococcal disease, known as meningitis, an uncommon but serious illness that teens and young adults aged 16-23 are at an increased risk for.Alyson Hannigan,...

GSK (LON:GSK) Will Pay A Dividend Of £0.16

The board of GSK plc (LON:GSK) has announced that it will pay a dividend on the 10th of July, with investors receiving £0.16 per share. This will take the dividend yield to an attractive 4.2%, providing a nice boost to shareholder returns. Our free stock report includes 4 warning signs investors should be aware of...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?